Magnesium Chloride (Mylan Institutional LLC)
Welcome to the PulseAid listing for the Magnesium Chloride drug offered from Mylan Institutional LLC. This Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional LLC |
| NON-PROPRIETARY NAME: | magnesium chloride |
| SUBSTANCE NAME: | MAGNESIUM CHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2013-03-14 |
| END MARKETING DATE: | 0000-00-00 |
Magnesium Chloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Magnesium Chloride from Mylan Institutional LLC |
| LABELER NAME: | Mylan Institutional LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/mL) |
| START MARKETING DATE: | 2013-03-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67457-134_5d074715-0142-4e7f-af09-2956d21c675e |
| PRODUCT NDC: | 67457-134 |
| APPLICATION NUMBER: | |
Other MAGNESIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
